Associated Papers
Hematologically important mutations: Leukocyte adhesion deficiency (second update).
Roos D et al.
Blood Cells, Molecules & Diseases, 2023
Leukocyte adhesion defect: Where do we stand circa 2019?
Das J et al.
Genes & Diseases, 2020
Leucocyte adhesion deficiency-A multicentre national experience.
Wolach B et al.
European Journal of Clinical Investigation, 2019
A Novel Nonsense Mutation in FERMT3 Causes LAD-III in a Pakistani Family.
Shahid S et al.
Frontiers in Genetics, 2019
Hematopoietic stem cell transplantation corrects osteopetrosis in a child carrying a novel homozygous mutation in the FERMT3 gene.
Palagano E et al.
Bone, 2017
Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation.
Stepensky PY et al.
Journal of Pediatric Hematology/oncology, 2015
Hematologically important mutations: leukocyte adhesion deficiency (first update).
van de Vijver E et al.
Blood Cells, Molecules & Diseases, 2012
A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin- and nonintegrin-related defects in different steps of leukocyte adhesion.
Robert P et al.
Journal of Immunology (baltimore, Md. : 1950), 2011
Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.
Jurk K et al.
Thrombosis and Haemostasis, 2010
LAD-1/variant syndrome is caused by mutations in FERMT3.
Kuijpers TW et al.
Blood, 2009
Leukocyte adhesion deficiency syndrome: a controversy solved.
Abram CL et al.
Immunology and Cell Biology, 0
Select a paper to view details